KTA
DGX icon

Keeley-Teton Advisors’s Quest Diagnostics DGX Stock Holding History

Keeley-Teton Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,786
Closed -$213K – 309
2020
Q4 		$213K Buy
1,786
+6
+0.3% +$731 0.03% 250
2020
Q3 		$204K Buy
1,780
+5
+0.3% +$591 0.03% 237
2020
Q2 		$202K Buy
+1,775
New +$188K 0.03% 238

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Keeley-Teton Advisors's DGX Position: Q1 2021 in Review

Keeley-Teton Advisors sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 1,786 shares — an estimated $213K sold.

Keeley-Teton Advisors first reported a position in DGX in Q2 2020 and held it in 3 quarters. The position peaked at $213K in Q4 2020. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Keeley-Teton Advisors reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Keeley-Teton Advisors sold 1,786 Quest Diagnostics shares in Q1 2021, an estimated $213K.
  • Keeley-Teton Advisors first reported a position in Quest Diagnostics in Q2 2020 and held it in 3 quarters.
  • Keeley-Teton Advisors's Quest Diagnostics position peaked at $213K in Q4 2020.
  • 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Keeley-Teton Advisors's 13F filing for Q1 2021, filed 14 May 2021.